Starpharma : CBCD Congratulates Starpharma (SPHRY) on the

New Post Public Reply Private Reply Replies (0) Message Board
tamerg

Starpharma : CBCD Congratulates Starpharma (SPHRY) on the Development of Its Virus Killing Condom
08/18/2014 | 12:01am US/EasternRecommend:
0
Rochester, NY (PRWEB) August 18, 2014

"Infected with the genital herpes virus (HSV-2)? The CBCD recommends taking Novirin or Gene-Eden-VIR." - Greg Bennett, CBCD

The Center for the Biology of Chronic Disease (CBCD) congratulates Starpharma, an Australian biomedical company, on the development of "a condom coated with a special gel that has been able to deactivate as much as 99.9 percent of viruses in laboratory testing." (1) The antiviral gel is called VivaGel and is designed to deactivate or destroy HIV, the herpes virus and the human papillomavirus (HPV), and will be marketed in Australia under the brand name LifeStyles Dual Protect. (1) So far, the condoms are only approved by the Australian health authorities. The CBCD looks forward to seeing a reduction in HPV, HSV, and HIV diagnoses in the Australian public, and to the introduction of these condoms to the American market. However, the CBCD reminds the public that approval of these condoms for American markets by the FDA may take time. Until then, the CBCD recommends two natural, safe and effective, HSV-2 remedies that are backed by clinical studies.

Click to learn more about genital herpes symptoms.

The Center for the Biology of Chronic Disease (CBCD) recommends that people infected with the genital herpes virus (HSV-2) take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (2) The study authors also wrote that, "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Even though the new condoms from Starpharma are coated with an antiviral gel, the CBCD reminds the public that genital herpes can be transmitted even when using condoms. As the CDC notes on its website, while condom use can reduce the risk of herpes transmission, "outbreaks can occur in areas that are not covered by a condom." (See the CDC, last updated February 13, 2013) (3)

What current treatments are available for herpes infections?

"Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day." (2). There are also natural antiviral products that studies show to be safe and effective in reducing herpes symptoms. Two of these products are Novirin and Gene-Eden-VIR.

"There are currently no FDA approved antiviral coated condoms against the genital herpes virus. Research shows that most drugs against HSV-2 only reduce outbreaks by one day. Thus, we recommend that infected individuals take Novirin or Gene-Eden-VIR, which are designed to help the immune system target the latent HSV-2." - Greg Bennett, CBCD

Interested individuals can view the two published studies on the Novirin and Gene-Eden-VIR formula here: http://www.scirp.org/journal/PaperInformation...-x7BeOSz90 and http://www.scirp.org/journal/PaperInformation...erID=44234.

To learn more about Novirin, visit http://www.novirin.com and about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

References:

(1) NYDailynews.com - Condoms armored with virus-killing lubricant will soon be available. Published July 24, 2014.
nydailynews.com/life-style/health/condoms-virus-killing-lube-article-1.1878467

(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. http://www.scirp.org/journal/PaperInformation...-x7BeOSz90

(3) CDC.com - Genital Herpes - CDC Fact Sheet. Last updated on February 13, 2013.
cdc.gov/std/herpes/stdfact-herpes-detailed.htm

Read the full story at http://www.prweb.com/releases/2014/08/prweb12095579.htm

Starpharma Holdings Ltd. (SPHRY) Stock Research Links

SPHRY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 4

Legal Troubles Mount for Innventure, Inc. Looks like Innventure, Inc. is caught in the kind of mess that even seasoned traders dread—a class action lawsuit hanging over its head like a storm cloud just bursting with lightning. If you're holding a piece of Innventure (NASDAQ: INV), this is one of those times when you've got to look your portfolio straight in the eye and...

Continue Reading
Norwegian Bella™: A New Era in Luxury Cruising

Updated Category News Views 6

Setting Sail with Norwegian Bella™ in 2028 When you hear about another cruise ship hitting the water, eye rolls might come naturally. But Norwegian Cruise Line's latest announcement adds a few twists worth noting. Today, the big news is that the Norwegian Bella™, the freshest face in NCL's innovative Prima Class, is now open for bookings. This beauty will start its...

Continue Reading
DaVita's Stand on HHS Kidney Plan: Innovation at Core

Updated Category News Views 3

DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...

Continue Reading
LAZ Parking and indiGOtech's Bold EV Charging Move

Updated Category News Views 9

EV Chargers: The Future Parked Closer? I've been around the block more times than a cabbie in Manhattan rush hour, and let me tell you, when it comes to EVs, folks are still playing catch-up. But here's a kicker—LAZ Parking and indiGOtech have decided they're not gonna wait around. This joint venture of theirs aims to sock some sense into the old condo complex parking...

Continue Reading
Anita Eno: 2027's Top Trailblazing Businesswoman

Updated Category News Views 4

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

Continue Reading
JinkoSolar Passes Key Resolutions Amid Name Change

Updated Category News Views 2

A New Chapter for JinkoSolar Right out of the gate, JinkoSolar has decided to shake things up, along with a new legal identity. The news coming from their 2026 annual general meeting confirms a significant shift in branding from ‘JinkoSolar Holding Co., Ltd’ to the new title of ‘Jinko Holdings Limited’. If you’ve been around the block like me, you’ll know that...

Continue Reading
ALS.Community Launches Free Online Support Platform

Updated Category News Views 13

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Continue Reading
Sunrate and TourMind Partner to Boost Travel Payments

Updated Category News Views 1

Travel Sector Eyes Major Payment Makeover Sunrate and TourMind are shaking hands in a big way, capitalizing on the blurring lines between digital connectivity and global travel demands. Their union is the latest bid to tackle financial snags and streamline operations in this ever-evolving market. I mean, who isn't fed up with clunky payment systems when jet-setting across...

Continue Reading
Software Tax Hits Enterprises: Costly Control Concerns

Updated Category News Views 12

Unanticipated Software Costs: Who's in Charge? Picture this: you're running a tech setup at a major corporation, but the software changes thrust upon you aren't anything you would've chosen freely. Yeah, that's about one in four dollars from your hot little budget spent on tweaks and adjustments you didn’t ask for. And it's not as glamorous as it sounds—more like a...

Continue Reading
Network Brainiacs Expands Footprint into Maryland Market

Updated Category News Views 9

Network Brainiacs Steps into Maryland Territory If you're in the tech services game, expansion stories are the bread and butter of this business. Network Brainiacs, a seasoned veteran in the managed IT and cybersecurity sectors, has taken their first big step into Maryland by acquiring Computer Enhancement Systems (CES), a notable player in the field, as of September 1,...

Continue Reading

Top 5 Most Recently Viewed Articles

Brown & Brown, Inc. Celebrates Workplace Recognitions in 2024

Updated Category News Views 85

Brown & Brown, Inc. Achieves Great Place To Work Certification Brown & Brown, Inc. is thrilled to announce that it has been certified by Great Place To Work for an impressive sixth consecutive year. This recognition comes alongside a distinguished spot on the 2024 Fortune Best Workplaces for Women list, marking the fourth year running. CEO J. Powell Brown and Chief People...

Continue Reading
AmeriFlex Revolutionizes Succession Planning with AI Scout

Updated Category News Views 21

AI Takes the Wheel in Advisor Succession Planning Sitting at the brink of a shift in financial planning, The AmeriFlex Group is taking succession planning by the reins, and this time they're doing it with a digital ace up their sleeve. Enter 'Scout,' an AI-powered dynamo designed to cut the time and effort it takes to identify financial advisors ready for succession. This...

Continue Reading
ThredUp Reports Strong Q3 2025 Revenue Growth and Insights

Updated Category News Views 198

ThredUp's Impressive Third Quarter Performance ThredUp Inc. (NASDAQ: TDUP) has unveiled remarkable financial results for its third quarter, showcasing its position as a leader in the online resale market. The company reported a record quarterly revenue of $82.2 million, marking a significant increase of 34% compared to the previous year. This achievement reflects...

Continue Reading
Sectra's Cloud Service Enhances Healthcare Across Multiple Sites

Updated Category News Views 159

Transforming Healthcare with Sectra's Cloud Solution In a significant advancement for healthcare delivery, an international medical imaging IT and cybersecurity company, Sectra, has successfully implemented its enterprise imaging solution, known as Sectra One Cloud, across a major multisite healthcare system. This progressive move highlights Sectra's commitment to...

Continue Reading
Medicenna Set to Showcase Breakthrough Cancer Therapies at Two Major Conferences

Updated Category News Views 108

Medicenna's Upcoming Presentations Highlight Innovative Cancer Therapies Medicenna Therapeutics Corp. (TSX: MDNA, OTCQX: MDNAF), a pioneering clinical-stage immunotherapy company known for its advanced research in cancer treatments, is excited to announce its participation in two eminent scientific conferences. The company plans to present significant pre-clinical...

Continue Reading